Sökning: WFRF:(Nuki G.) > (2004) > The need for clinic...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 04172naa a2200445 4500 | |
001 | oai:lup.lub.lu.se:71bb56de-955b-4f38-b7db-e7c15d76f15c | |
003 | SwePub | |
008 | 160401s2004 | |||||||||||000 ||eng| | |
024 | 7 | a https://lup.lub.lu.se/record/8988322 URI |
024 | 7 | a https://doi.org/10.1007/s00198-004-1621-62 DOI |
040 | a (SwePub)lu | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a for2 swepub-publicationtype |
072 | 7 | a ref2 swepub-contenttype |
100 | 1 | a Boonen, S4 aut |
245 | 1 0 | a The need for clinical guidance in the use of calcium and vitamin D in the management of osteoporosis: a consensus report |
264 | c 2004-04-07 | |
264 | 1 | b Springer Science and Business Media LLC,c 2004 |
520 | a A European Union (EU) directive on vitamins and minerals used as ingredients of food supplements with a nutritional or physiological effect (2002/46/EC) was introduced in 2003. Its implications for the use of oral supplements of calcium and vitamin D in the prevention and treatment of osteoporosis were discussed at a meeting organized with the help of the World Health Organization ( WHO) Collaborating Center for Public Health Aspects of Rheumatic Diseases (Liege, Belgium) and the support of the WHO Collaborating Center for Osteoporosis Prevention (Geneva, Switzerland). The following issues were addressed: Is osteoporosis a physiological or a medical condition? What is the evidence for the efficacy of calcium and vitamin D in the management of postmenopausal osteoporosis? What are the risks of self-management by patients in osteoporosis? From their discussions, the panel concluded that: (1) osteoporosis is a disease that requires continuing medical attention to ensure optimal therapeutic benefits; (2) when given in appropriate doses, calcium and vitamin D have been shown to be pharmacologically active (particularly in patients with dietary deficiencies), safe, and effective for the prevention and treatment of osteoporotic fractures; (3) calcium and vitamin D are an essential, but not sufficient, component of an integrated management strategy for the prevention and treatment of osteoporosis in patients with dietary insufficiencies, although maximal benefit in terms of fracture prevention requires the addition of antiresorptive therapy; (4) calcium and vitamin D are a cost-effective medication in the prevention and treatment of osteoporosis; (5) it is apparent that awareness of the efficacy of calcium and vitamin D in osteoporosis is still low and further work needs to be done to increase awareness among physicians, patients, and women at risk; and (6) in order that calcium and vitamin D continues to be manufactured to Good Manufacturing Practice standards and physicians and other health care professionals continue to provide guidance for the optimal use of these agents, they should continue to be classified as medicinal products. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Ortopedi0 (SwePub)302112 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Orthopaedics0 (SwePub)302112 hsv//eng |
653 | a calcium | |
653 | a fracture prevention | |
653 | a vitamin D | |
653 | a osteoporosis drugs | |
700 | 1 | a Rizzoli, R4 aut |
700 | 1 | a Meunier, PJ4 aut |
700 | 1 | a Stone, M4 aut |
700 | 1 | a Nuki, G4 aut |
700 | 1 | a Syversen, U4 aut |
700 | 1 | a Lehtonen-Veromaa, M4 aut |
700 | 1 | a Lips, P4 aut |
700 | 1 | a Johnell, Olofu Lund University,Lunds universitet,Ortopedi - klinisk och molekylär osteoporosforskning,Forskargrupper vid Lunds universitet,Orthopedics - Clinical and Molecular Osteoporosis Research,Lund University Research Groups4 aut0 (Swepub:lu)orto-ojo |
700 | 1 | a Reginster, JY4 aut |
710 | 2 | a Ortopedi - klinisk och molekylär osteoporosforskningb Forskargrupper vid Lunds universitet4 org |
773 | 0 | t Osteoporosis Internationald : Springer Science and Business Media LLCg 15:7, s. 511-519q 15:7<511-519x 1433-2965x 0937-941X |
856 | 4 | u http://dx.doi.org/10.1007/s00198-004-1621-6y FULLTEXT |
856 | 4 8 | u https://lup.lub.lu.se/record/898832 |
856 | 4 8 | u https://doi.org/10.1007/s00198-004-1621-6 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
Kopiera och spara länken för att återkomma till aktuell vy